Sailong Pharmaceutical GroupLtd Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Ownership Breakdown

What is the ownership structure of 002898?
Owner Type	Number of Shares	Ownership Percentage
Institutions	8,248,601	4.69%
Private Companies	14,040,813	7.98%
General Public	53,656,648	30.5%
Individual Insiders	100,053,938	56.8%

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.

Top Shareholders

Top 20 shareholders own 69.51% of the company

Ownership	Name	Shares	Current Value	Change %	Portfolio %
51.2%	Nan Gui Cai	90,016,937	CN¥903.8m	0%	no data
7.25%	Zhuhai Huangqin New Area Sailong Juzhi Investment Co., Ltd.	12,756,260	CN¥128.1m	-5.26%	no data
5.47%	Lin Tang	9,631,882	CN¥96.7m	0%	no data
0.58%	Goldman Sachs Group, Investment Banking and Securities Investments	1,014,051	CN¥10.2m	179%	no data
0.53%	Shenyin Wanguo Asset Management (Asia) Limited	930,400	CN¥9.3m	0%	0.09%
0.52%	Everbright Asset Management Co., Ltd.	920,540	CN¥9.2m	0%	0.12%
0.52%	CITIC Securities Company Limited, Asset Management Arm	908,374	CN¥9.1m	0%	0.01%
0.4%	Zhuhai Huangqin New Area Saipu Investment Center (Limtied Partnership)	703,317	CN¥7.1m	0%	no data
0.4%	Huatai Securities (Shanghai) Asset Management Co., Ltd.	700,800	CN¥7.0m	50.7%	0.06%
0.38%	JPMorgan Chase & Co, Private Banking and Investment Banking Investments	673,497	CN¥6.8m	0%	no data
0.38%	China International Capital Corporation Hong Kong Asset Management Limited	670,581	CN¥6.7m	0%	0.04%
0.37%	JPMorgan Chase & Co, Brokerage and Securities Investments	646,470	CN¥6.5m	0%	no data
0.35%	Morgan Stanley, Investment Banking and Brokerage Investments	615,478	CN¥6.2m	-78.9%	no data
0.33%	Zhuhai Huangqin New Area Saijie Investment Center (Limtied Partnership)	581,236	CN¥5.8m	0%	no data
0.32%	Barclays PLC Private Banking & Investment Banking Investment	555,810	CN¥5.6m	88.9%	no data
0.32%	Shanghai Lanxi Asset Management Co., Ltd.	554,600	CN¥5.6m	0%	no data
0.23%	Chong Hua Zong	404,019	CN¥4.1m	0%	no data
0.019%	Lion Fund Management Co. Ltd.	33,200	CN¥333.3k	0%	no data
0.014%	Fortune And Royal Asset Management Co., Ltd.	24,800	CN¥249.0k	0%	0.01%
0.00063%	Jianfeng Li	1,100	CN¥11.1k	0%	no data

Company Analysis and Financial Data Status

Data	Last Updated (UTC time)
Company Analysis	2025/01/31 21:57
End of Day Share Price	2025/01/27 00:00
Earnings	2024/09/30
Annual Earnings	2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

Package	Data	Timeframe	Example US Source ^*
Company Financials	10 years	Income statement Cash flow statement Balance sheet	SEC Form 10-K SEC Form 10-Q
Analyst Consensus Estimates	+3 years	Forecast financials Analyst price targets	Analyst Research Reports Blue Matrix
Market Prices	30 years	Stock prices Dividends, Splits and Actions	ICE Market Data SEC Form S-1
Ownership	10 years	Top shareholders Insider trading	SEC Form 4 SEC Form 13D
Management	10 years	Leadership team Board of directors	SEC Form 10-K SEC Form DEF 14A
Key Developments	10 years	Company announcements	SEC Form 8-K

^* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Sailong Pharmaceutical Group Co.,Ltd. is covered by 2 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

Analyst	Institution
Yifan Jiang	China Merchants Securities Co. Ltd.
Jiaxi Xu	Industrial Securities Co. Ltd.